Regeneus Ltd (ASX:RGS) Chairman's Address to Shareholders and CEO Presentation
Regeneus Ltd (ASX:RGS) provides the Company's Chairman's address to shareholders and CEO presentation at 2017 Annual General Meeting.
Companies in the News
Biotech
Regeneus Ltd (ASX:RGS) Presentation on Japan First Strategy at Ord Minnett
Regeneus Ltd (ASX:RGS) provides the Company's Presentation on Japan First Strategy at Ord Minnett.
Queensland Bauxite Ltd (ASX:QBL) Quarterly Activities and Cashflow Report
During the September Quarter 2017, Queensland Bauxite Limited (ASX:QBL) continued to press to progress the development of its flagship South Johnstone DSO bauxite project in northern Queensland, with the Company aiming to generate positive net cash flows in the short term through the commencement of DSO bauxite production and shipping.
Queensland Bauxite Ltd (ASX:QBL) Anticipated Cashflow from MCL Investment
The Board of Queensland Bauxite (ASX:QBL) is most excited to announce that via its subsidiary Medical Cannabis Ltd, the initial sample range of hemp products under the name Vitahemp, will be ready for introduction to the Australian market in November 2017. Hemp foods are an extremely nutritious form of food product made from low THC Cannabis.
Nanollose Ltd (ASX:NC6) Sustainable Fibre Company Commences Trading on the ASX
Nanollose Limited (ASX:NC6), an innovative Plant-Free Cellulose technology company, is pleased to announce that it will commence trading on the Australian Stock Exchange under ASX code NC6 at 1:00pm ADST today, following the successful completion of its Initial Public Offering.
dorsaVi (ASX:DVL) Receives $1.1m Federal Government Advanced Manufacturing Growth Fund Grant to Support Enhancements to Current Manufacturing Facilities
dorsaVi (ASX:DVL) is pleased to announce it has received a Federal Government Advanced Manufacturing Growth Fund grant of more than $1.1m. This Federal fund was established to help industry adjust to the wind-down of car manufacturing in Victoria and South Australia. The fund is focused on advanced manufacturing activities that will boost innovation, skills and employment opportunities.
Anatara Lifesciences Ltd (ASX:ANR) Investor Presentation
Anatara Lifesciences (ASX:ANR) is pleased to release its latest institutional roadshow presentation and market update that will be delivered to investors this week by CEO & Chairman, Dr Mel Bridges and Co-Founder and Chief Scientific Officer, Dr Tracey Mynott.
◂Previous Page
Biotech Next Page▸
Banking & Finance
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
Social Media
